| Product Code: ETC6165158 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia Oncology NGS Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia Oncology NGS Market - Industry Life Cycle |
3.4 Armenia Oncology NGS Market - Porter's Five Forces |
3.5 Armenia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Armenia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Armenia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Armenia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Armenia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Armenia Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Armenia |
4.2.2 Rising demand for personalized medicine in oncology treatment |
4.2.3 Technological advancements in next-generation sequencing (NGS) for oncology research |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and testing |
4.3.2 Limited awareness and access to advanced oncology diagnostics in Armenia |
5 Armenia Oncology NGS Market Trends |
6 Armenia Oncology NGS Market, By Types |
6.1 Armenia Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Armenia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Armenia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Armenia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Armenia Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Armenia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Armenia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Armenia Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Armenia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Armenia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Armenia Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Armenia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Armenia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Armenia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Armenia Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Armenia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Armenia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Armenia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Armenia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Armenia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Armenia Oncology NGS Market Import-Export Trade Statistics |
7.1 Armenia Oncology NGS Market Export to Major Countries |
7.2 Armenia Oncology NGS Market Imports from Major Countries |
8 Armenia Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technology in oncology diagnostics in Armenia |
8.2 Number of oncology research studies utilizing NGS technology |
8.3 Rate of integration of genomic data into clinical practice in oncology sector |
9 Armenia Oncology NGS Market - Opportunity Assessment |
9.1 Armenia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Armenia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Armenia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Armenia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Armenia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Armenia Oncology NGS Market - Competitive Landscape |
10.1 Armenia Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Armenia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here